🇺🇸 FDA
Patent

US 6096727

Method for treating wounds using modified hyaluronic acid crosslinked with biscarbodiimide

expired A61KA61K47/36A61K47/61

Quick answer

US patent 6096727 (Method for treating wounds using modified hyaluronic acid crosslinked with biscarbodiimide) held by ANIKA THERAPEUTICS, INC. expires Mon Jul 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
ANIKA THERAPEUTICS, INC.
Grant date
Tue Aug 01 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K47/36, A61K47/61, A61K47/6903, A61K9/0014